Table 4.
Multivariate analysis by logistic regression
β | SE | p value | OR (95% CI) | |
---|---|---|---|---|
Poor sleep quality (PSQI ≥ 8.5) as a dependent variable | ||||
All subjects (n = 115) | ||||
Depression (BDI-II ≥ 14) | 1.618 | 0.469 | 0.001 | 5.043 (2.012–12.640) |
Leukopenia | –1.475 | 0.512 | 0.004 | 0.229 (0.084–0.625) |
Pilocarpine usage | 1.031 | 0.450 | 0.022 | 2.804 (1.160–6.779) |
Subjects without depression (n = 71) | ||||
Unsatisfactory symptom state (ESSPRI ≥ 5) | 1.505 | 0.586 | 0.010 | 4.505 (1.428–14.214) |
Ever-smoking | 1.988 | 0.976 | 0.042 | 7.298 (1.078–49.422) |
Subjects with depression (n = 44) | ||||
Leukopenia | –3.068 | 1.111 | 0.006 | 0.047 (0.005–0.410) |
Age | 0.120 | 0.050 | 0.017 | 1.128 (1.021–1.245) |
Unsatisfactory symptom state (ESSPRI ≥ 5) as a dependent variable | ||||
Fatigue (FSS ≥ 4) | 2.393 | 0.542 | 1.00 × 10–5 | 10.942 (3.784–31.635) |
PGA, the 4th quartile | 2.011 | 0.772 | 0.009 | 7.469 (1.645–33.915) |
Poor sleep quality | 1.162 | 0.513 | 0.023 | 3.197 (1.171–8.731) |
PD usage | 1.388 | 0.657 | 0.035 | 4.006 (1.105–14.526) |
SE, standard error; OR, odds ratio; CI, confidence interval; PSQI, Pittsburgh Sleep Quality Index; BDI, Beck Depression Inventory; ESSPRI, European League Against Rheumatism (EULAR) Sjögren’s syndrome (SS) Patient Reported Index; FSS, fatigue severity score; PGA, patient global assessment for SS; PD, prednisolone.